GPT and infection: We found that the prevalence of abnormal ALT was reduced from 75% during first infection to 25% upon rechallenge (Fig. 7 B), and in those rare cases where ALT was increased in the second or third infection, adverse events were mild (not moderate or severe) even though pathogen load was increased.